論文(2016)

英文原著

  1. Andreeff M, Kelly KR, Yee K, Assouline S, Strair R, Popplewell L, Bowen D, Martinelli G, Drummond MW, Vyas P, Kirschbaum M, Iyer SP, Ruvolo V, González GM, Huang X, Chen G, Graves B, Blotner S, Bridge P, Jukofsky L, Middleton S, Reckner M, Rueger R, Zhi J, Nichols G, Kojima K　Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia　Clin Cancer Res.  22:868-876. 　2016

  2. Hosoya K, Matsusaka S, Kashiwada T, Suzuki K, Ureshino N, Sato A, Miki Y, Kitera K, Hirai M, Hatake K, Kimura S, Sueoka-Aragane N　Detection of KRAS Mutations in plasma DNA using a fully automated rapid detection system in colorectal cancer patients　Pathol Oncol Res, 2017 Jan 5. doi: 10.1007/s12253-016-0175-1　2017

  3. Ide M, Koba K, Sueoka-Aragane N, Sato A, Nagano Y, Inoue T, Misago N, Narisawa Y, Kimura S, Sueoka E　Mutation profile of B-raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients　Pathol Oncol Res　23:181-188 2017

  4. Imamura Y, Kawayama T, Kinoshita T, Sakazaki Y, Yoshida M, Takahashi K, Fujii K, Ando M, Hoshino T, Iwanaga T, Kohrogi H; Kyushu Asthma Seminar Investigators. Poor pharmacological adhearance to inhaled medications compared with oral medications in Japanese patients with asthma and chronic obstructive pulmonary disease.　Allegol Int　2017

  5. Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, Borthakur G, Mu H, Zeng Z, Tabe Y, Allen JE, Wang Z, Ma W, Lee HC, Orlowski R, Sarbassov dos D, Lorenzi PL, Huang X, Neelapu SS, McDonnell T, Miranda RN, Wang M, Kantarjian H, Konopleva M, Davis RE, Andreeff M　ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies　Sci Signal. 9:ra17.       2016

  6. Ishizawa J, Sugihara E, Kuninaka S, Mogushi K, Kojima K, Benton CB, Zhao R, Chachad D, Hashimoto N, Jacamo RO, Qiu Y, Yoo SY, Okamoto S, Andreeff M, Kornblau SM, Saya H　FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B cell acute leukemia.　Blood, in press 2016

  7. Itamura H, Shindo T, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S.　The MEK Inhibitor Trametinib Separates Murine Graft-versus-Host Disease from Graft-versus-Tumor Effects.　JCI Insight 1: e86331 2016

  8. Kojima K, Maeda A, Yohimura M, Nishida Y, Kimura S　The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma.　Oncotarget 7: 69625-69637　2016

  9. Komiya K, Nakamura T, Sadamatsu H, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N　SPARC is a Possible Predictive Marker for Albumin-bound Paclitaxel in Non-small Cell Lung Cancer.   OncoTargets and Therapy 9：6663-6668　2016

  10. ＊Kurimoto M, Suzuki H, Aoki K, Ohka F, Kondo G, Motomura K, Iijima K, Yamamichi A, Ranjit M, Wakabayashi T, Kimura S, Natsume A. Rapid sensitive analysis of IDH-1 mutation in low-grade gliomas by automated genetic typing involving a quenching probe.　Cancer Invst 34: 12-15　2016

  11. ＊Matsuda Y, Yamauchi T, Hosono N, Uzui K, Negoro E, Morinaga K, Nishi R, Yoshida A, Kimura S, Maekawa T. Ueda T. 　The combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells.  Cancer Sci 107: 1029-1038 　2016

  12. ＊Miyamura K, Miyamoto T, Tanimoto M, Yamamoto K, Kimura S, Kawaguchi T, Matsumura I, Hata T, Tsurumi H, Saito S, Hino M, Tadokoro S, Meguro K, Hyodo H, Yamamoto M, Kubo K, Tsukada J, Kondo M, Aoki M, Okada H, Yanada M, Ohyashiki K, Taniwaki M. 　Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.　Leuk Res　51: 11-18   2016

  13. Morita N, Yamai I, Takahashi K, Kusumoto Y, Shibata T, Kobayashi T, Nonaka MI, Ichimonji I, Takagi H, Miyake K, Takamura SA　C4b binding protein negatively regulates TLR1/2 response.　Innate Immun; 23: 11-19:　2017

  14. ＊Nemoto A, Saida D, Kato I, Kikuchi J, Furukawa Y, Maeda Y, Akahane K, Honna-Oshiro H, Goi K, Kagami K, Kimura S, SatoY, Okabe S, Niwa A, Watanabe K, Nakahata T, Heike T, Sugita K. Inukai T. 　pecific anti-leukemic activity of PD0332991, a CDK4/6 inhibitor, against Philadelphia-chromosome positive lymphoid leukemia.   Mol Cancer Ther 15: 94-105　2016

  15. "Y Nishida, A Maeda, MJ Kim, L Cao, Y Kubota, J Ishizawa, A AlRawi, Y Kato, A Iwama, M Fujisawa, K Matsue, M Weetall, M Dumble, M Andreeff, TW Davis, A Branstrom, S Kimura, K Kojima"   The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells  Blood Cancer Journal (2017) 7, e527; doi:10.1038/bcj.2017.8  2017

  16. ＊Okabe M, Yamaguchi H, Usuki K, Kobayashi Y, Kawada E, Kuroda J, Kimura S, Tajika K, Gomi S, Arima N, Mori S, Ishida Y, Koizumi M, Ito Y, Wakita S, Araua K, Kitano T, Kosaka F, Dan K, Inokuchi K.  Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L/K mutations.  Leuk Res 40: 68-76  2016

  17. Sakata S, Saeki S, Okamoto I, Otsubo K, Komiya K, Morinaga R, Yoneshima Y, Koga Y, Enokizu A, Kishi H, Hirosako S, Yamaguchi E, Aragane N, Fujii S, Harada T, Iwama E, Semba H, Nakanishi Y, Kohrogi H Phase II trial of weekly nab-paclitaxel for previously treated advancednon–small cell lung cancer: Kumamoto thoracic oncology study group(KTOSG) trial 1301  Lung Cancer 2016 Sep;99:41-5  2016

  18. Sueoka-Aragane N, Katakami N, Miyako M, Yokota S, Aoe K, Iwanaga K, Otsuka K, Morita S, Kimura S, Negoro S.     Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.  Cancer Sci 107: 162-167  2016

  19. Tashiro H, Takahashi K, Tanaka M, Komiya K, Nakamura T, Kimura S, Tada Y, Sueoka-Aragane N  Characteristics and prognosis of microscopic polyangiitis with bronchiectasis, Journal of Thoracic Disease  Journal of Thoracic Disease  2017

  20. Tashiro H, Takahashi K, Hayashi S, Kato G, Kurata K, Kimura S, Sueoka-Aragane N.  Interleukin-33 from monocytes recruited to the lung contributes to house dust mite-induced airway inflammation in a mouse model.  PLoS One 11: e0157571  2016

  21. Ureshino H, Shindo T, Nishikawa H, Watanabe N, Watanabe E, Satoh N, Kitaura K, Kitamura H, Doi K, Nagase K, Kimura H, Sakurai R, Baba R, Kurogi K, Samukawa M, Kusunoki S, Miyahara M, Suzuki R, Sakaguchi S, Kimura S.     Effector regulatory T cells reflects antitumor immunity and autoimmunity.   Cancer Immunol Res 4 :644-649  2016

  22.  Watanabe T, Sato A, Kobayashi-Watanabe N, Sueoka-Aragane N, Kimura S, Sueoka E.   Torin2 potentiates anti-cancer effects for adult T-cell leukemia/lymphoma by inhibiting mammalian target of rapamycin.   Anticancer Res 36: 95-102  2016

症例報告、Letter to the editor

  1. 土井和子、嬉野博志、宮原正晴、古江増隆     Kaposi肉腫の2例 西日本皮膚科 78:44-49        2016

  2. Kitamura H, Kubota Y, Fukushima N, Ichinohe T, Hayasaka D, Kamachi K, Yoshihara M, Itamura H, Hisatomi T, Wakayama K, Sueoka E, Kimura S.       Famotidine-induced reactive plasmacytosis and generalized lymphadenopathy: a case report and review of the literature.  Int J Clin Exp Pathol 9: 7680-7685 2016

  3. Kitamura H, Shindo T, Yakushiji Y, Yoshihara M, Eriguchi M, Kubota Y, Noguchi T, Kimura S.   Domino-style cerebral bleeding in immune thrombocytopenic purpura. JAMA Neurology 73: 474-475  2016

  4. Kubota Y, Ichinohe T, Yoshimura M, Itamura H, Hisatomi T, Fukushima N, Sueoka E, Kimura S.  Acute myeloid leukemia with t(3;8)(q26;q24) complicated by diabetes insipidus. Ann Hematol 95: 653-655  2016

  5. Kusaba K, Kojima K, Naito S, Taba M, Kai K, Ureshino H, Nishida Y, Kimura S  Paraneoplastic sarcoidosis in multiple myeloma Intern Med,, in press  2016

  6. Nishioka A, Kubota Y, Sueoka E, Kimura S.   Severe L-asparaginase-induced liver steatosis in mixed phenotype acute leukemia. (Pictures in Clinical Medicine)    Intern Med 55: 1025-1026 2016

  7. Sadamatsu H, Takahashi K, Tashiro H, Komiya K, Nakamura T, Sueoka-Aragane N,  Successful treatment of pulmonary nocardiosis with Fluoroquinolone in bronchial asthma and bronchiectasis  Respirology Case Reports 2017

  8. Tashiro H, Takahashi K, Sadamatsu H, Uchida M, Kimura S, Sueoka-Aragane N  Chronic and Asymptomatic Diffuse Alveolar Haemorrhage with Microscopic Polyangiitis: A Case Report and Review of the Literature.  Case Rep Rheumatol. :1658126  2016

  9. Tashiro H, Takahashi K, Nakamura T, Komiya K, Kimura S. Sueoka-Aragane N.  Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report. J Med Case Rep 10; 113-116  2016

  10. Ureshino H, Nishioka A, Kojima K, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.  Subdural hematoma associated with dasatinib and intrathecal methotrexate treatment in Philadelphia chromosome-positive acute lymphoblastic leukemia.   Int Med 55: 2703-2706   2016

  11. Ureshino H, Tanabe M, Kurogi K, Miyahara M, Kimura S  Acute Megakaryoblastic Leukemia with Myelodysplasia-related Changes Associated with ATM Gene Deletion.  Intern Med 55: 1625-1629  2016

  12. Ureshino H, Nishioka A, Kojima K, Suzuki M, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.   Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma  Intern Med 55: 2061-2064  2016

  13. Ureshino H, Miyahara M   Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia  Ann Hematol 95: 841-843  2016

  14. Ureshino H, Miyahara M   Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer  Ann Hematol 95:1743-1744  2016

  15. Ureshino H, Kizuka H, Kusaba K, Sano H, Nishioka A, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S  5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10) Int J Hematol online first  2016

英文総説

  1. Kimura S.  Current Status of ABL Tyrosine Kinase Stop Studies for Chronic Myeloid Leukemia. Stem Cell Invest 3: 36-42  2016   

日本語総説

  1. 荒金尚子      血漿遊離DNAの有用性と臨床応用   呼吸器内科, 29 (3), 203-208  2016   

  2. 荒金尚子      ctDNAによる薬剤耐性遺伝子検出と次治療決定における有用性    実験医学, 34 (14) , 2364-2368  2016   

  3. 木村晋也      慢性白血病       ライフライン、23：18-21         2016   

  4. 木村晋也      第2世代TKI抵抗性CMLの病態とその克服       血液内科72: 562-568   2016   

  5. 木村晋也      ABL阻害剤止痒患者における微小残存病変の検出とストップ試験. 血液フロンティア 26: 29-36    2016   

  6. 木村晋也      STOP試験の現状.         血液フロンティア 26: 51-59     2016   

  7. 小島研介，木村晋也  T315I変異に対する治療 白血病・リンパ腫薬物療法ハンドブック 162-167      南江堂，東京    2016

  8. 小島研介，木村晋也  Ph陰性骨髄増殖性腫瘍〜分子病態と治療の最前線〜        医薬ジャーナル社 34-44         医薬ジャーナル社、大阪 2016

  9. 小島研介，木村晋也  最新の基礎研究動向：概論、多発性骨髄腫学       日本臨牀社　139-143    日本臨牀社，東京           2016

  10. 小島研介      急性白血病の診断と治療 蕗書房　14−17 蕗書房，神奈川 2016

  11. 久保田寧      赤芽球癆と胸腺過形成    Medical Practice 33:1822        2016   

  12. 田代宏樹、髙橋浩一郎          ダニ抗原による気道炎症マウスモデルにおいて肺に集積する単球はIL-33のセルソースである         臨床免疫・アレルギー科 2017   

  13. 嬉野博志、木村晋也  血液疾患領域の新規治療薬2016「ポナチニブ」  Hematology agora: 11-14      2016   

  14. ○山田尚友、山田麻里江、中尾真実、久保田寧、末岡榮三朗    移植医療における輸血関連検査　輸血とHLA (human leukocyte antigen) 検査について   日本検査血液学会雑誌 17:434-440        2016

日本語著書

  1. 木村晋也　第4章 管理・治療：チロシンキナーゼ阻害剤：特性の違い.　診断と治療のABC 113.　慢性骨髄性白血病、骨髄増殖性腫瘍（木村文彦企画）　122-130 木村文彦企画    　2016

  2. 木村晋也　慢性骨髄性白血病（2nd TKIs の適応）　白血病学（下）162-165　日本臨牀増刊号　2016

  3. 木村晋也　TKIsによるCML治療のモニタリングと予後予測. EBM血液疾患の治療　153-156　金倉譲、木崎昌弘、鈴木律朗、神田善伸編集　2016

 

最終更新日：2017年4月28日

 

(C)佐賀大学医学部附属病院血液・呼吸器・腫瘍内科